| Serial Number | 79272524 |
| Word Mark | ELEVECTA |
| Filing Date | Monday, August 12, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 28, 2020 |
| Registration Number | 6110170 |
| Registration Date | Tuesday, July 28, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 12, 2020 |
| Goods and Services | Medicines for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; pharmaceutical and veterinary products, preparations and reagents for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; chemical, biological and biochemical substances, preparations and reagents for medical and veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; diagnostic and analytical preparations for medical and veterinary purposes; cultures of microorganisms and viruses for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for medical or veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, for medical and veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing viral vectors, in particular vectors of adeno-associated viruses, for medical, veterinary and medical diagnostic purposes |
| Goods and Services | Chemical, biological and biochemical reagents for scientific, research, laboratory, industrial and commercial purposes; Chemical, biological and biochemical substances and preparations for scientific, research and laboratory use; chemical, biological and biochemical substances, preparations and reagents for research use in characterizing diseases; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals; cultures of microorganisms and viruses, other than for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells for scientific, research, laboratory, industrial and commercial purposes, namely, for manufacturing viral vectors, in particular vectors of adeno-associated viruses |
| Goods and Services | Scientific and industrial research, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures, and expression systems in the nature of microorganisms, insect cells, and mammalian cells; scientific, technical and industrial research consultancy, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific laboratory services, namely, cultivation, extraction, optimization, synthesizing and modifying of eukaryotic cell lines, eukaryotic cells, in particular transfecting and selecting of eukaryotic cells and eukaryotic cell lines with a nucleic acid, in particular a plasmid, viruses, in particular adeno-associated viruses, viral vectors, in particular vectors of adeno-associated viruses, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific analysis, research and development in the nature of analysis and selection of transfected eukaryotic cells and eukaryotic cell lines and viral vectors, in particular vectors of adeno-associated viruses, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Friday, January 3, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, November 21, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, November 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 26, 2019 | ASSIGNED TO EXAMINER |
| Friday, November 29, 2019 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, December 3, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 4, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 2, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 17, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 24, 2020 | REFUSAL PROCESSED BY IB |
| Wednesday, March 18, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 1, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 17, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 22, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 12, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 12, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 28, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 17, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, October 28, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, November 16, 2020 | FINAL DISPOSITION PROCESSED |
| Friday, June 11, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 11, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 13, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, December 6, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, June 11, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, June 11, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 13, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 13, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, July 13, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 21, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 21, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 21, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, August 21, 2023 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Monday, August 21, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 21, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, August 21, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, November 19, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 9, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, August 9, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, August 9, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, August 9, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 18, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 9, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, August 9, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |